|
Research about transplant, cell production, etc.
|
|
Cultivations in Lab May Usher in New Era for Corneal Transplants. David Hwang, MD, a UCSF Director
of ophthalmology is working on
replicating corneal endothelial
cells in vitro. Not much
has been done to re-implant them
in donor cornea.
|
|
Cellular
Transformation and the
Extracellular Matrix in Corneal
Wound Healing. This is
the Canadian research location
where we think the cornea was
cloned.
|
|
McMaster's University Chemical Engineering.
Research on artificial corneas.
Dr. H. Sheardown.
|
|
Review of Optometry Online taken from the Handbook of Ocular Disease Management.
A clinical description and discussion of Fuchs'. The print is small.
|
|
Clinical Specular Microscropy.
By Ronald A. Laing, Ph.D.
In Vivo Findings of Specular Microscopy.
|
|
National Center for Biotechnology Information
Extract from a National
Institute of Health
Database. Links to many
other medical and genetic
databases.
"Fuchs' Endothelial Dystrophy--A fresh look at an aging disease," - which includes this statement of interest, "The current trend is to intervene surgically before the patient reaches the painful end-stage," and this
|
|
Oxford University (UK) Useful Vision Links.
|
|
JAMA archives
General Medical Search Facility
|
|
Merck's Manual of Diagnosis and Therapy
Brief description of Fuchs'
Then see this section which states that
one reason for corneal transplant is "to alleviate pain,
e.g., to relieve the severe
foreign-body sensation due to
recurrent ruptured bullae in
bullous keratopathy
(pseudophakic, Fuchs' endothelial
dystrophy, aphakic)."
|
